Viewing Study NCT05363592


Ignite Creation Date: 2025-12-24 @ 3:30 PM
Ignite Modification Date: 2025-12-26 @ 7:52 AM
Study NCT ID: NCT05363592
Status: COMPLETED
Last Update Posted: 2023-01-12
First Post: 2022-04-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Bioequivalence Study of CT-L01 Compared to Co-administration (ALO 12.5 mg and MET XR 500 mg) in Healthy Volunteers
Sponsor: Celltrion
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module